Congenital CMV in Australia: Reported Cases Are a Small Fraction of Estimated Burden — Implications for Screening, Treatment, and Public Health
Highlight
– National prospective APSU surveillance (1999–2024) identified 586 reported congenital CMV cases, 479 of them definite, but this represents only ~1% of expected cases based on developed-country prevalence estimates.
– The common clinical manifestations included intrauterine growth restriction/small for gestational age, sensorineural hearing loss, microcephaly, hepatic involvement, and thrombocytopenia.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.